IDIX (MM)

CAMBRIDGE, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview, including an update of the company's commercialization activities and discovery and development programs, at the upcoming Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Thursday, February 8, 2007 at 8:40 a.m. EST at The Grand Hyatt Hotel in New York. The live and archived audio only webcast of the presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://ir.idenix.com/phoenix.zhtml?c=131556&p=irol-calendar. Please log in approximately 10 minutes before the call to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the presentation. The presentation will be available for download in PDF format in the "Investor Presentations" section of the Investor Center immediately following the presentation. About Idenix Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV). For further information about Idenix, please refer to http://www.idenix.com/. Idenix Pharmaceuticals' Contacts: Media: Teri Dahlman (617) 995-9905 Investors: Amy Sullivan (617) 995-9838 DATASOURCE: Idenix Pharmaceuticals, Inc. CONTACT: For media, Teri Dahlman, +1-617-995-9905, For investors, Amy Sullivan, +1-617-995-9838, both of Idenix Pharmaceuticals, Inc. Web site: http://www.idenix.com/

Copyright